Peter Kenneth Gillman, Ken Gillman, P Ken Gillman
Peter Kenneth Gillman, Ken Gillman, P Ken Gillman
PsychoTropical research
Verified email at - Homepage
Cited by
Cited by
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
PK Gillman
British journal of pharmacology 151 (6), 737-748, 2007
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
PK Gillman
British journal of anaesthesia 95 (4), 434-441, 2005
The serotonin syndrome and its treatment
PK Gillman
Journal of Psychopharmacology 13 (1), 100-109, 1999
Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction
RR Ramsay, C Dunford, PK Gillman
British journal of pharmacology 152 (6), 946-951, 2007
A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action
PK Gillman
Biological psychiatry 59 (11), 1046-1051, 2006
Serotonin toxicity associated with the use of linezolid: a review of postmarketing data
KR Lawrence, M Adra, PK Gillman
Clinical infectious diseases 42 (11), 1578-1583, 2006
Serotonin syndrome: history and risk
PK Gillman
Fundamental & clinical pharmacology 12 (5), 482-491, 1998
CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
PK Gillman
Journal of Psychopharmacology 25 (3), 429-436, 2011
Selective inhibitors of monoamine oxidase type B and the “cheese effect”
JPM Finberg, K Gillman
International review of neurobiology 100, 169-190, 2011
Neuroleptic malignant syndrome: mechanisms, interactions, and causality
PK Gillman
Movement disorders 25 (12), 1780-1790, 2010
Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review
P Ken Gillman
Headache: The Journal of Head and Face Pain 50 (2), 264-272, 2010
Methylene blue implicated in potentially fatal serotonin toxicity
PK Gillman
Anaesthesia 61 (10), 1013-1014, 2006
A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status
PK Gillman
Human Psychopharmacology: Clinical and Experimental 21 (2), 117-125, 2006
Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan
PK Gillman, JR Bartlett, PK Bridges, A Hunt, AJ Patel, BD Kantamaneni, ...
Journal of Neurochemistry 37 (2), 410-417, 1981
Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium
SC Stanford, BJ Stanford, PK Gillman
Journal of Psychopharmacology 24 (10), 1433-1438, 2010
Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors
PK Gillman
Journal of clinical psychopharmacology 31 (1), 66-74, 2011
Human platelet phenolsulphotransferase: separate control of the two forms and activity range in depressive illness
SMB Carter, V Glover, M Sandler, PK Gillman, PK Bridges
Clinica Chimica Acta 117 (3), 333-344, 1981
Linezolid and serotonin toxicity
PK Gillman
Clinical infectious diseases 37 (9), 1274-1275, 2003
Fatal methylene blue associated serotonin toxicity
WM Top, PK Gillman, CJ De Langen, A Kooy
Neth J Med 72 (3), 179-181, 2014
Substances related to 5‐hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients
G Curzon, BD Kantamaneni, P Van Boxel, PK Gillman, JR Bartlett, ...
Acta Psychiatrica Scandinavica 61 (S280), 3-20, 1980
The system can't perform the operation now. Try again later.
Articles 1–20